CATX — Perspective Therapeutics Share News
0.000.00%
Last trade - 00:00- $183.78m
- -$51.49m
- $0.88m
U.S. RESEARCH ROUNDUP- Amerant Bancorp, BlackRock, Equinix
Brief: Perspective Therapeutics On Sept 18, Entered Into Master Equipment And Services Agreement & Statements Of Work Thereunder With Comecer SpA
U.S. RESEARCH ROUNDUP- Advance Auto Parts, Molina Healthcare, Walmart
Brief: Perspective Therapeutics Says May Offer And Sell Shares Of Common Stock Of Up To $250 Mln
U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop
Brief: Perspective Therapeutics Announces Pricing Of $80 Million Underwritten Offering Of Common Stock And Pre-Funded Warrants
Brief: Perspective Therapeutics Inc Files For Mixed Shelf Offering Size Not Disclosed- SEC Filing
U.S. RESEARCH ROUNDUP-AN2 Therapeutics, Ecolab, RPM International
Brief: Perspective Therapeutics Said Amendment Changes The Termination Date, As Defined In The Agreement, From March 31, 2024, To April 30, 2024.
Brief: Perspective Therapeutics Files For Shelf Of Up To 148.35 Million Shares Of Common Stock By Selling Stockholders
Live Markets: Big pharma's FOMO will lead to more radio M&A
Brief: Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility
Brief: Perspective Therapeutics Announces $87.4 Million Private Placement
Brief: Perspective Therapeutics Announces Pricing Of $60.0 Million Public Offering And $20.8 Million Private Placement
Brief: Perspective Therapeutics Announces Proposed Public Offering
Brief: Perspective Therapeutics Look Forward To Provide Safety And Efficacy Updates In 2H 2024
Brief: Perspective Therapeutics Enters Into Strategic Agreements With Lantheus
Brief: Gt Medical Technologies To Buy All Of Radioactive Cesium-131 Seed Assets And Related Business From Isoray Medical
Brief: Perspective Therapeutics Says Co Entered At Market Issuance Sales Agreement With Oppenheimer & Co, B. Riley Securities